If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
8.50    0.00 (0.00%)
Bid:
8.00
Ask:
9.00
Spread: 1.00 (12.50%)
Market Cap: £3.80m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Update

Today 07:00

RNS Number : 6014L
Jarvis Securities plc
09 July 2026
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Jarvis Securities plc

("Jarvis" or the "Company" and with its subsidiaries the "Group")

Update

On 7 July 2025 Jarvis announced (the "Announcement") that its wholly owned subsidiary Jarvis Investment Management Limited ("JIML") has sold its retail execution only brokerage business, for a total consideration of up to £11m to Interactive Investor Services Limited (the "Transaction"). The £9m initial consideration was paid to JIML straight away with the remaining £2 million of the consideration deferred for up to c.18 months and subject to potential adjustment for claims under the sale agreement ("Deferred Consideration"), 

The Company is pleased to announce that JIML has now received the first Deferred Consideration payment of £1m plus accrued interest, for a total payment of c.£1,029,000. The second and final Deferred Consideration payment, also of £1m (subject to potential adjustment for claims under the sale agreement) is due on or around 7 January 2027.

At this stage it is intended that JIML will retain these funds during the wind down process after which any surplus will be available for the benefit of the Company, if JIML has not been sold pursuant to the potential sale process announced on 5 May 2026. At this stage there can be no certainty as to the timing of any sale of JIML or that it will occur at all. Full details of the proposed disposal are set out in the Company's announcement of 5 May 2026.

Further updates will be provided in due course.

Steve Middleton, Non-executive Director of Jarvis Securities Plc, has approved this announcement and authorised its release.

Enquiries

Jarvis Securities plc

 01892 510 515

Andrew Grant

Zeus Capital (Nominated Adviser)

020 3829 5000 

Katy Mitchell / Liv Highton)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSSWFAAEMSEDW
Date   Source Headline
8th Aug 20131:38 pmRNSDirector's Interest
24th Jul 20137:00 amRNSInterim Results and Dividend Declaration
18th Jul 201311:44 amRNSAdditional Listing and Total Voting Rights
29th May 20137:00 amRNSExercise of Options
15th May 20134:07 pmRNSExercise of Options
14th May 20137:00 amRNSTrading Update and Dividend Declaration
29th Apr 20139:30 amRNSExercise of Options
25th Apr 20139:05 amRNSDirector's Interest
21st Mar 20139:20 amRNSResult of AGM
12th Mar 20134:19 pmRNSExercise of Options and Director's Interest
25th Feb 20132:47 pmRNSExercise of Options and Director's Interest
21st Feb 20137:00 amRNSFinal Results
19th Feb 20137:00 amRNSExercise of Options
14th Feb 20132:47 pmRNSExercise of Options
13th Feb 20137:00 amRNSDividend Declaration
5th Feb 20133:50 pmRNSCorrection: Exercise of Options
5th Feb 201311:58 amRNSExercise of Options
10th Jan 20137:00 amRNSSale of Investment in Hubwise Holdings Limited
9th Jan 20133:30 pmRNSExercise of Options
11th Dec 20127:00 amRNSDirector's Interest
7th Dec 20129:01 amRNSDirector's Interest
20th Nov 20127:00 amRNSDirector/PDMR Shareholding
14th Nov 201212:18 pmRNSDividend Declaration
12th Nov 201212:18 pmRNSDirector/PDMR Shareholding
23rd Oct 20127:00 amRNSDirector/PDMR Shareholding
17th Sep 20124:24 pmRNSExercise of Options
12th Sep 201211:12 amRNSExercise of Options
26th Jul 20127:01 amRNSDividend Declaration
26th Jul 20127:00 amRNSInterim Results
23rd Jul 20125:24 pmRNSAdditional Listing
2nd Jul 20127:00 amRNSDirectorate Change
21st Jun 20127:00 amRNSChange of Adviser
10th May 20122:23 pmRNSAdditional Listing
9th May 20123:31 pmRNSDividend Declaration
22nd Mar 201212:12 pmRNSResult of AGM
28th Feb 20123:13 pmRNSAdditional Listing
28th Feb 20122:45 pmRNSDirector/PDMR Shareholding
28th Feb 20129:04 amRNSAdditional Listing
23rd Feb 201211:15 amRNSDirector/PDMR Shareholding
23rd Feb 201210:38 amRNSDividend - amendment to DRIP date
22nd Feb 201212:06 pmRNSDividend Declaration
22nd Feb 20127:00 amRNSFinal Results, Annual report and AGM Notice
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
28th Dec 20112:49 pmRNSDirector/PDMR Shareholding
6th Dec 20113:55 pmRNSDirector's Dealing
11th Nov 20113:34 pmRNSReplacement - Dividend Declaration
11th Nov 201111:01 amRNSDividend Declaration
17th Aug 201110:51 amRNSDirectors' Dealing
26th Jul 201112:02 pmRNSReplacement - Interim Results
26th Jul 20117:00 amRNSInterim Results - Six months ended 30 June 2011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.